Increasing Cases of Retroperitoneal Fibrosis After Covid-19: Case Report, Did She Die Retroperitoneal Fibrosis or Cancer?

Year 2024, Volume: 15 Issue: 1, 12 - 15, 29.03.2024

Gülnihal Deniz , Mürteza Çakır , Serpil Bılgın Akyagcı

https://doi.org/10.33706/jemcr.1419408

Abstract

This case report details the unfortunate journey of a 59-year-old breast cancer survivor who developed secondary Retroperitoneal Fibrosis (RPF) in 2022. Despite diligent treatment efforts, her condition took a devastating turn when, in June 2023, she was diagnosed not only with persistent RPF but also with advanced liver, omental, and duodenal cancer. Tragically, her condition deteriorated rapidly, leading to her passing on day 41 following her presentation. This case underscores the challenges of diagnosing and treating RPF. It highlights the importance of considering cancer development in advanced RPF cases that do not respond to treatment, often leaving limited options for effective intervention.

Keywords

Retroperitoneal Fibrosis, Liver Cancer, Metastasis, Steroid, Azathioprine.

Ethical Statement

Necessary permissions were obtained from the first degree family.

Thanks

We would like to thank the deceased A. S. and her precious family for their contributions to science.

References

• 1. ŞEKERCİ ÇA. Experience with treatment of retroperitoneal fibrosis: Collaboration of urology and nephrology departments for 26 years in Marmara University. 2017.
• 2. Lee SJ, Eun JS, Kim MJ, Song YW, Kang YM. Association of retroperitoneal fibrosis with malignancy and its outcomes. Arthritis Research & Therapy. 2021;23:1-9.
• 3. Runowska M, Majewski D, Puszczewicz M. Retroperitoneal fibrosis–the state-of-the-art. Reumatologia/Rheumatology. 2016;54(5):256-63.
• 4. Chen T, Tian L, Fan D, Wu F, Lu J, Ding S. Retroperitoneal fibrosis secondary to non-urology carcinomas: a clinical and outcome analysis of 97 cases. Clinical and Translational Oncology. 2019;21:373-9.
• 5. Cansu DÜ. Retroperitoneal fibrozis: Ayırıcı tanı ve tedavi. Journal of Turkish Society for Rheumatology. 2022;14.
• 6. Goldoni M, Bonini S, Urban ML, Palmisano A, De Palma G, Galletti E, et al. Asbestos and smoking as risk factors for idiopathic retroperitoneal fibrosis: a case–control study. Annals of internal medicine. 2014;161(3):181-8.
• 7. Raglianti V, Rossi GM, Vaglio A. Idiopathic retroperitoneal fibrosis: an update for nephrologists. Nephrology Dialysis Transplantation. 2021;36(10):1773-81.
• 8.Giannese D, Moriconi D, Cupisti A, Zucchi A, Pastore AL, Simonato A, et al. Idiopathic Retroperitoneal Fibrosis: What Is the Optimal Clinical Approach for Long-Term Preservation of Renal Function? Urologia Internationalis. 2023;107(2):134-47.
• 9. Karbasi A, Karbasi-Afshar R, Ahmadi J, Saburi A. Retroperitoneal fibrosis as a result of signet ring cell gastric cancer: a case-based review. Journal of gastrointestinal cancer. 2013;44:94-7.
• 10. Urban M, Palmisano A, Nicastro M, Corradi D, Buzio C, Vaglio A. Idiopathic and secondary forms of retroperitoneal fibrosis: a diagnostic approach. La Revue de medecine interne. 2015;36(1):15-21.